Glenmark’s Immune-Boosting Cancer Drug Candidate Gains FDA Approval for Clinical Trials
Glenmark Pharmaceuticals, a leading global pharmaceuticals company, has announced that its investigational drug candidate, GRC 54276, has received approval from the US Food and Drug Administration (FDA) to proceed with…
ObvioHealth and Mi-Helper Partner to Conduct Remote Trial for Non-Invasive Migraine Treatment Device
ObvioHealth and Mi-Helper, Inc. have joined forces to conduct a decentralized clinical trial for a novel, non-invasive device that aims to tackle migraines. This pioneering randomized controlled trial will be…
Homeopathy treatment protocols are able to reduce thyroid stimulating hormone readings in 52% patients
Homeopathic treatment protocol developed at Dr Kalyan Banerjee’s Clinic are effective in reducing thyroid stimulating hormone readings in 52% hypothyroidism patients within the first follow-up. The results were based on…
Elevate Addiction Services Integrates Vivalink Platform for Real-Time Detox Monitoring in Inpatient Treatment
Vivalink, a leading provider of digital healthcare solutions, announces its biometric data platform has been successfully integrated into Elevate Addiction Services’ drug and alcohol in-patient detox treatment program. Vivalink’s Biometrics…
At Apollo Hospitals, a 59-year-old man successfully has robotic surgery to treat his esophageal diverticulum
In a rare case of esophageal diverticulum, a 59 year old man from Yangon, Myanmar underwent a successful robot assisted minimally invasive surgery at Indraprastha Apollo Hospitals (apollohospitaldelhi).The man had been complaining…
Breakthrough Technology Could Lead to One-Time HIV Treatment
TAU researchers demonstrate initial success in neutralizing the virus with a single vaccine Researchers from Tel Aviv University demonstrated the success of a novel technology that may be developed into…
Hospitals in Delhi are fast-filling as patients with breathing problems increase
The impact of deteriorating air quality in the national capital is now visible in the outpatient departments of hospitals in the city. Cases of pollution-related ailments have spiked in the…
DCGI approved AstraZeneca’s Lynparza as a monotherapy for adjuvant treatment of patients with high-risk early breast cancer
AstraZeneca India, a leading science-led biopharmaceutical company, today announced that it has received a Drugs Controller General of India (DCGI) approval to market its drug Lynparza (Olaparib) as a monotherapy…
